The Valley Desk

NCT00114218 · Interventional trial

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Overall registry status Completed

Phase 2

Conditions Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov